Top Drivers of Global Laboratory Centrifuge Market
|
By LabMedica International staff writers Posted on 29 Jan 2018 |

Image: The global laboratory centrifuge market is expected to grow steadily during the forecast period 2017-2022, driven by three main factors (Photo courtesy of Technavio Research).
The global laboratory centrifuge market is expected to grow steadily at a CAGR of more than 5% during the forecast period 2017-2022, driven mainly by the increasing number of biotechnology and pharmaceutical research studies, growing use of molecular diagnostics in hospitals, and technological advancements.
These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.
Increasing number of biotechnology and pharmaceutical research studies
The biotechnology and pharmaceutical sector is being driven by a large unmet demand for the medical needs of the people. These industries are recording consistent growth owing to the advent of new diseases and continuous drug discovery. Since innovations require better treatments and product delivery, research in these sectors acts as a backbone for these industries.
Increasing use of molecular diagnostics in hospitals
There has been an increase in the treatment of diseases at the molecular level in hospitals in order to determine diseases elaborately and provide the complete profiling of diseases. Microcentrifuges and mini centrifuges are used in large-sized hospitals and diagnostics centers to separate body fluids. The high throughput and easy maintenance of laboratory centrifuges have propelled their demand among hospitals.
Technological advancements
Laboratory centrifuges are undergoing rapid technological transformations, including changes in design and material in their interiors and rotors. Centrifuges have also witnessed changes in their structure and function. Various types of benchtop and floor standing centrifuges are available, based on their speed and functions. For instance, microcentrifuges and ultra-centrifuges provide high speed and better resolution.
Over the next few years, next-generation centrifuge systems will gain traction in the laboratory centrifuge market. The emergence of Internet of Things (IoT) has led to the introduction of smart centrifuges known as next-generation centrifuge systems, which overcome the speed, space and volume limitations of conventional centrifuge systems. Next-generation centrifuge systems also provide indications and assistance to users, and come with automatic electric brakes, speed control mechanisms, and safety features.
In 2017, the benchtop centrifuges segment held the largest share of the medical centrifuge market, as their smaller footprint and cost-effectiveness makes them an ideal solution for laboratories and diagnostics centers with space and budget constraints. The Americas is expected to be the major revenue contributor to the global laboratory centrifuge market over the forecast period. The US and Canada dominate the region’s medical centrifuge market due to the presence of several laboratories and academic institutions, and a well-established healthcare industry in these countries. Additionally, growing research activities in the Latin American countries will also fuel the growth of the laboratory centrifuge market in this region.
The laboratory centrifuge market is fragmented due to the presence of several players. A majority of the market share is held by the key players who compete with each other on the basis of price, quality, and new innovations. These players are investing heavily in R&D in order to remain competitive in the medical centrifuge market.
Related Links:
Technavio Research
These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.
Increasing number of biotechnology and pharmaceutical research studies
The biotechnology and pharmaceutical sector is being driven by a large unmet demand for the medical needs of the people. These industries are recording consistent growth owing to the advent of new diseases and continuous drug discovery. Since innovations require better treatments and product delivery, research in these sectors acts as a backbone for these industries.
Increasing use of molecular diagnostics in hospitals
There has been an increase in the treatment of diseases at the molecular level in hospitals in order to determine diseases elaborately and provide the complete profiling of diseases. Microcentrifuges and mini centrifuges are used in large-sized hospitals and diagnostics centers to separate body fluids. The high throughput and easy maintenance of laboratory centrifuges have propelled their demand among hospitals.
Technological advancements
Laboratory centrifuges are undergoing rapid technological transformations, including changes in design and material in their interiors and rotors. Centrifuges have also witnessed changes in their structure and function. Various types of benchtop and floor standing centrifuges are available, based on their speed and functions. For instance, microcentrifuges and ultra-centrifuges provide high speed and better resolution.
Over the next few years, next-generation centrifuge systems will gain traction in the laboratory centrifuge market. The emergence of Internet of Things (IoT) has led to the introduction of smart centrifuges known as next-generation centrifuge systems, which overcome the speed, space and volume limitations of conventional centrifuge systems. Next-generation centrifuge systems also provide indications and assistance to users, and come with automatic electric brakes, speed control mechanisms, and safety features.
In 2017, the benchtop centrifuges segment held the largest share of the medical centrifuge market, as their smaller footprint and cost-effectiveness makes them an ideal solution for laboratories and diagnostics centers with space and budget constraints. The Americas is expected to be the major revenue contributor to the global laboratory centrifuge market over the forecast period. The US and Canada dominate the region’s medical centrifuge market due to the presence of several laboratories and academic institutions, and a well-established healthcare industry in these countries. Additionally, growing research activities in the Latin American countries will also fuel the growth of the laboratory centrifuge market in this region.
The laboratory centrifuge market is fragmented due to the presence of several players. A majority of the market share is held by the key players who compete with each other on the basis of price, quality, and new innovations. These players are investing heavily in R&D in order to remain competitive in the medical centrifuge market.
Related Links:
Technavio Research
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







